阿波罗内外科公司（纳斯达克股票代码：APEN）2月份空头利率下降59.0％

Apollo Endosurgery, Inc. (NASDAQ:APEN – Get Rating) was the recipient of a significant drop in short interest in February. As of February 15th, there was short interest totalling 566,200 shares, a drop of 59.0% from the January 31st total of 1,380,000 shares. Based on an average daily volume of 1,650,000 shares, the short-interest ratio is currently 0.3 days.

Institutional Investors Weigh In On Apollo Endosurgery

Institutional investors have recently bought and sold shares of the company. Lazard Asset Management LLC boosted its stake in Apollo Endosurgery by 77.5% in the second quarter. Lazard Asset Management LLC now owns 10,904 shares of the biotechnology company's stock valued at $39,000 after acquiring an additional 4,762 shares in the last quarter. Walleye Capital LLC purchased a new position in shares of Apollo Endosurgery in the second quarter worth $44,000. Jump Financial LLC purchased a new position in shares of Apollo Endosurgery in the third quarter worth $62,000. OLD Mission Capital LLC purchased a new position in shares of Apollo Endosurgery in the second quarter worth $65,000. Finally, Wolverine Asset Management LLC purchased a new position in shares of Apollo Endosurgery in the fourth quarter worth $67,000. 76.01% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on APEN. Stifel Nicolaus downgraded shares of Apollo Endosurgery from a "buy" rating to a "hold" rating and set a $10.00 price objective on the stock. in a research note on Tuesday, January 3rd. Cowen downgraded shares of Apollo Endosurgery from an "outperform" rating to a "market perform" rating and dropped their price objective for the company from $13.00 to $10.00 in a research note on Monday, January 23rd. Finally, Lake Street Capital downgraded shares of Apollo Endosurgery from a "buy" rating to a "hold" rating and dropped their price objective for the company from $14.00 to $10.00 in a research note on Wednesday, November 30th.

Apollo Endosurgery Price Performance

APEN traded up $0.01 during trading on Thursday, hitting $9.94. The stock had a trading volume of 82,854 shares, compared to its average volume of 1,664,043. Apollo Endosurgery has a twelve month low of $3.49 and a twelve month high of $10.30. The company has a debt-to-equity ratio of 1.26, a current ratio of 6.00 and a quick ratio of 4.98. The stock has a 50 day simple moving average of $9.91 and a two-hundred day simple moving average of $7.77.

About Apollo Endosurgery

(Get Rating)

Apollo Endosurgery, Inc is a medical technology company, which focuses on the design, development, and commercialization of medical devices to advance gastrointestinal therapeutic endoscopy. It offers Endoscopy, Surgical and Other products. The firm's endoscopy product portfolio consists of the OverStitch Endoscopic Suturing System, the OverStitch Sx Endoscopic Suturing System, and the Orbera Intragastric Balloon System.

See Also

• Get a free copy of the StockNews.com research report on Apollo Endosurgery (APEN)
• Hormel Hits 2-Year Low, And The Dip Gets Bought
• Here's Why Ross Could Soon Be Hitting All Time Highs
• The Bottom Is In For Salesforce.com
• It's Time For A Fresh Look At The Kroger Co.
• West Fraser's Earnings Scream Timber, Outlook Says Buy

Receive News & Ratings for Apollo Endosurgery Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apollo Endosurgery and related companies with MarketBeat.com's FREE daily email newsletter.